Long-term safety and efficacy of daclizumab beta in relapsing-remitting multiple sclerosis : 6-year results from the SELECTED open-label extension study
-
Gold, Ralf (Ruhr-University Bochum)
;
Radue, Ernst-Wilhem (University Hospital Basel (Basilea, Suïssa)) ;
Giovannoni, Gavin (Queen Mary University of London) ;
Selmaj, Krzysztof. (University of Warmia and Mazury) ;
Havrdova, Eva Kubala (Charles University) ;
Montalban, Xavier (Hospital Universitari Vall d'Hebron) ;
Stefoski, Dusan (Rush University Medical Center) ;
Sprenger, Till (DKD Helios Klinik Wiesbaden) ;
Robinson, Randy R. (AbbVie Inc.) ;
Fam, Sami (Biogen) ;
Smith, Jonathan (Biogen) ;
Chalkias, Spyros (Biogen) ;
Giannattasio, Giorgio (Biogen) ;
Lima, Gabriel (Biogen) ;
Castro-Borrero, Wanda (Biogen) ;
Universitat Autònoma de Barcelona
visitant ::
identificació
Subscriure's to this discussion. You will then receive all new comments by email.
